Deutsche Bank Ag\ Foghorn Therapeutics Inc. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
A detailed history of Deutsche Bank Ag\ transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 12,310 shares of FHTX stock, worth $52,933. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,310
Previous 7,840
57.02%
Holding current value
$52,933
Previous $45,000
153.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding FHTX
# of Institutions
81Shares Held
33.3MCall Options Held
8.7KPut Options Held
2.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$54.5 Million20.03% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$22.8 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$13 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.88 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$7.45 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $179M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...